MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Biotechnology_Personalized, Precision, Preemptive Medicines
Aposense
Attachments
Aposense
Parents
*Architects: Biotechnology_Personalized, Precision, Preemptive Medicines
*Architects: Medical Imaging (Molecular, Functional-PET, Gamma & Nuclear Medicine) Company
*Industry: Israel
Children
Aposense
Aposense wins NIH funding for brain tumor trial
Aposense® is translating the science of Apoptosis (programmed cell death) into personalized patient care in multiple disease categories, including oncology, cardiology and neurology
Founded 1996
Petach Tikva, Israel
Pipeline of products based on its patented platform technology for targeting apoptosis (programmed cell death) in vivo.
Jumps
UPMC (University of Pittsburgh Medical Center) _ (Pittsburgh): 40 hospitals